Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066)-Reference-Cited by-同舟云学术

Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066)

Published:2011-06-30 Issue:5 Volume:15 Page:1018-1026
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

de Koning Pieter D.¹,McAndrew Douglas¹,Moore Robert¹,Moses Ian B.¹,Boyles David C.²,Kissick Kyle²,Stanchina Corey L.²,Cuthbertson Timothy³,Kamatani Asayuki³,Rahman Leera³,Rodriguez Rick³,Urbina Armando³,Sandoval (née Accacia) Alison⁴,Rose Peter R.⁴

Affiliation:

1. Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

2. Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, Michigan 48105, United States

3. Pfizer Global Research and Development, 10578 Science Center Drive, San Diego, California 92121, United States

4. Pfizer Global Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/op200131n

Reference16 articles.

1. An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

2. Pfizer pipeline as of Feb 28, 2011:http://www.pfizer.com/files/research/pipeline/2011_0228/pipeline_2011_0228.pdf.

3. Crizotinib — Latest Champion in the Cancer Wars?

4. Cui, J. J.; Botrous, I.; Shen, H.; Tran-Dube, M. B.; Nambu, M. D.; Kung, P.P.; Funk, L. A.; Jia, L.; Meng, J. J.; Pairish, M. A.; McTigue, M.; Grodsky, N.; Ryan, K.; Alton, G.; Yamazaki, S.; Zou, H.; Christensen, J. G.; Mroczkowski, B.Abstracts of Papers; 235th ACS National Meeting, New Orleans, LA, United States, April 6–10, 2008.

5. Cui, J. J.; Funk, L. A.; Jia, L.; Kung, P.P.; Meng, J. J.; Nambu, M. D.; Pairish, M. A.; Shen, H.; Tran-Dube, M. B.U.S. Pat. Appl. U. S. 2006/0046991 A1, 2006.

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manganese catalyzed asymmetric transfer hydrogenation of hindered ketones bearing a 2,6-disubstituted phenyl group;Journal of Catalysis;2024-10

2. Azole‐Substituted Triazole Formation through Organocatalytic Cycloaddition of β‐keto Azoles and Aryl Azides;ChemistrySelect;2024-09-12

3. A First-in-Class Pyrazole-isoxazole Enhanced Antifungal Activity of Voriconazole: Synergy Studies in an Azole-Resistant Candida albicans Strain, Computational Investigation and in Vivo Validation in a Galleria mellonella Fungal Infection Model;Journal of Medicinal Chemistry;2024-08-08

4. Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022;Results in Chemistry;2024-01

5. Unsaturated (C(sp2/sp)–B) Boronic Acid Derivatives;Reference Module in Chemistry, Molecular Sciences and Chemical Engineering;2024